{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:04:23Z","timestamp":1790611463549,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C108-217"],"award-info":[{"award-number":["TSGH-C108-217"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D-110050"],"award-info":[{"award-number":["TSGH-D-110050"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-111231"],"award-info":[{"award-number":["TSGH-E-111231"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-C-11116-111057"],"award-info":[{"award-number":["MND-MAB-C-11116-111057"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016817","name":"University of Maryland School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijantimicag.2023.107044","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T06:50:55Z","timestamp":1701327055000},"page":"107044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospective propensity score-matched study"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-0618","authenticated-orcid":false,"given":"Sheng-Huei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-3749","authenticated-orcid":false,"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-2557","authenticated-orcid":false,"given":"Chung-Kan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.107044_bib0001","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013515118","article-title":"Filling the gaps in the global prevalence map of clinical antimicrobial resistance","volume":"118","author":"Oldenkamp","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0003","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmi.2019.03.014","article-title":"Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment","volume":"25","author":"Piperaki","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0004","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106344","article-title":"Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant gram-negative bacilli","volume":"57","author":"Scudeller","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0006","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijantimicag.2014.10.002","article-title":"In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis","volume":"45","author":"Ni","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0008","doi-asserted-by":"crossref","first-page":"w14368","DOI":"10.4414\/smw.2016.14368","article-title":"Prolonged administration of \u03b2-lactam antibiotics: a comprehensive review and critical appraisal","volume":"146","author":"Osthoff","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-016-1197-5","article-title":"Treatment of gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?","volume":"20","author":"Bassetti","year":"2016","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2023.107044_bib0010","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0012","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2147\/IDR.S225518","article-title":"Clinical outcomes of colistin in combination with either 6-G sulbactam or carbapenems for the treatment of extensively drug-resistant Acinetobacter Baumannii pneumonia with high MIC to sulbactam, a prospective cohort study","volume":"12","author":"Ungthammakhun","year":"2019","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0013","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/IDR.S234211","article-title":"Colistin plus carbapenem versus colistin monotherapy in the treatment of carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"12","author":"Shi","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0014","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1177\/0300060519879336","article-title":"Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem","volume":"47","author":"Park","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0015","article-title":"Is it possible to eradicate carbapenem-resistant Acinetobacter baumannii (CRAB) from endemic hospitals?","volume":"11","author":"Medioli","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0016","doi-asserted-by":"crossref","first-page":"908.e1","DOI":"10.1016\/j.cmi.2017.10.033","article-title":"Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Liang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0017","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2017.10.018","article-title":"Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia","volume":"51","author":"Park","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0018","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/resp.12698","article-title":"Nosocomial Acinetobacter pneumonia: treatment and prognostic factors in 356 cases","volume":"21","author":"\u00d6zvatan","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0019","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.cmi.2021.01.020","article-title":"Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant gram-negative bacterial pneumonia: a multi-centre observational study","volume":"27","author":"Feng","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-022-03947-9","article-title":"The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study","volume":"26","author":"Wang","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0021","first-page":"1700582","volume":"50","author":"Torres","year":"2017","journal-title":"European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01864-19","article-title":"The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes","volume":"58","author":"Weinstein","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0023","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0024","doi-asserted-by":"crossref","first-page":"e99101","DOI":"10.1371\/journal.pone.0099101","article-title":"Effects of group 1 versus group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship","volume":"9","author":"Yoon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/cc6994","article-title":"Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use","volume":"12","author":"Slama","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0026","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dkw355","article-title":"High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii","volume":"72","author":"Lenhard","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0028","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/mdr.2012.0250","article-title":"In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection","volume":"19","author":"Principe","year":"2013","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.diagmicrobio.2008.11.002","article-title":"The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using E test and time-kill assay","volume":"63","author":"Pankey","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2007.07.007","article-title":"Comparative activities of colistin, rifampicin, imipenem and sulbactam\/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases","volume":"30","author":"Tripodi","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3343\/alm.2016.36.2.124","article-title":"In vitro interactions of antibiotic combinations of colistin, tigecycline, and doripenem against extensively drug-resistant and multidrug-resistant Acinetobacter baumannii","volume":"36","author":"Park","year":"2016","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2217\/fmb.14.34","article-title":"Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date","volume":"9","author":"Durante-Mangoni","year":"2014","journal-title":"Fut Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0034","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/cc4869","article-title":"Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0035","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1097\/01.CCM.0000089936.09573.F3","article-title":"Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study","volume":"31","author":"Garnacho","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0036","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00134-005-2598-0","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings","volume":"31","author":"Garnacho-Montero","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0037","unstructured":"Kaye K.S. Trial for the treatment of extensively drug-resistant gram-negative bacilli. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01597973 (accessed October 20, 2023)."},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0038","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.107044_bib0039","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/microorganisms9071505","article-title":"Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage?","volume":"9","author":"Roger","year":"2021","journal-title":"Microorganisms"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:49:12Z","timestamp":1760377752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0924857923003333"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107044","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospective propensity score-matched study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107044"}}